Trial Profile
Late Phase 2 Study of Paricalcitol Injection: Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Subjects Receiving Haemodialysis With Secondary Hyperparathyroidism (Examination of Initial Dose and Incremental Dose)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary) ; Maxacalcitol
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 18 Jun 2014 New trial record
- 14 Apr 2009
- 12 Jan 2009